Literature DB >> 19720336

Pregnancy-associated breast cancer: significance of early detection.

MaryAnn Ulery1, Linnette Carter1, Barbara L McFarlin1, Carmen Giurgescu1.   

Abstract

Pregnancy-associated breast cancer (PABC) is defined as cancer of the breast diagnosed during pregnancy and up to 1 year postpartum. Delays in diagnosis are frequently associated with increased morbidity and mortality. The aim of this article is to determine the significance of early detection of PABC and to alert health care providers to include PABC in the differential diagnosis when evaluating a breast mass in the perinatal period. This integrative literature review evaluated 15 research studies by using the hypothetical deductive model of clinical reasoning to determine factors related to diagnosis of PABC. As women delay childbearing, the incidence of PABC increases with age. In the reviewed studies, breast cancer was diagnosed with greater frequency in the postpartum period than during any trimester in pregnancy. Delay in diagnosis is complicated by axillary lymph node metastasis, high-grade tumors at diagnosis, and poor outcomes. Early detection is a significant predictor of improved outcomes. Diagnostic modalities such as ultrasound, mammography, and biopsy can be safely used for diagnostic purposes in the evaluation of potential cases of PABC during pregnancy.

Entities:  

Mesh:

Year:  2009        PMID: 19720336     DOI: 10.1016/j.jmwh.2008.12.007

Source DB:  PubMed          Journal:  J Midwifery Womens Health        ISSN: 1526-9523            Impact factor:   2.388


  7 in total

1.  Malignancies associated with pregnancy: an analysis of 21 clinical cases.

Authors:  Y Liu; Y Liu; Y Wang; X Chen; H Chen; J Zhang
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

2.  Placenta-breast cancer cell interactions promote cancer cell epithelial mesenchymal transition via TGFβ/JNK pathway.

Authors:  Gali Epstein Shochet; Shelly Tartakover-Matalon; Liat Drucker; Metsada Pasmanik-Chor; Meir Pomeranz; Ami Fishman; Michael Lishner
Journal:  Clin Exp Metastasis       Date:  2014-10-15       Impact factor: 5.150

3.  miR-21 Expression in Pregnancy-Associated Breast Cancer: A Possible Marker of Poor Prognosis.

Authors:  Beatriz A Walter; Gabriela Gómez-Macias; Vladimir A Valera; Mark Sobel; Maria J Merino
Journal:  J Cancer       Date:  2011-02-07       Impact factor: 4.207

4.  Clinical presentation and causes of the delayed diagnosis of breast cancer in patients with pregnancy associated breast cancer.

Authors:  Ali M Al-Amri
Journal:  J Family Community Med       Date:  2015 May-Aug

5.  Clinicopathological characteristics, diagnosis, and prognosis of pregnancy-associated breast cancer.

Authors:  Bin Wang; Yanfang Yang; Zhansheng Jiang; Jing Zhao; Yiran Mao; Jun Liu; Jin Zhang
Journal:  Thorac Cancer       Date:  2019-03-28       Impact factor: 3.500

6.  Long-Term Breast Cancer Outcomes of Pregnancy-Associated Breast Cancer (PABC) in a Prospective Cohort.

Authors:  Hyunji Jo; Seri Park; Hye Ryeon Kim; Hongsik Kim; Joohyun Hong; Jeong Eon Lee; Jonghan Yu; Byung Joo Chae; Se Kyung Lee; Jai Min Ryu; Soo-Young Oh; Suk Joo Choi; Ji-Yeon Kim; Jin Seok Ahn; Young-Hyuck Im; Eun Mi Nam; Seok Jin Nam; Yeon Hee Park
Journal:  Cancers (Basel)       Date:  2022-10-04       Impact factor: 6.575

7.  Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences.

Authors:  Fedro Alessandro Peccatori; Matteo Lambertini; Giovanna Scarfone; Lino Del Pup; Giovanni Codacci-Pisanelli
Journal:  Cancer Biol Med       Date:  2018-02       Impact factor: 4.248

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.